Sectors
GPCR
Structure Therapeutics Inc.
45.91
2 x 36.54
2 x 64.00
bid
ask
-
1.46
3.08%
2 @ 04:55 PM
45.08 -0.83 (1.81%)
| Ytd | -33.99% | |
| 1y | 137.88% |
45.10
day range
47.38
18.49
52 week range
94.90
| Open | 47.08 | Prev Close | 47.37 | Low | 45.10 | High | 47.38 | Mkt Cap | 3.27B |
| Vol | 1.32M | Avg Vol | 723.33K | EPS | -3.03 | P/E | N/A | Forward P/E | -21.71 |
| Beta | -1.51 | Short Ratio | 10.71 | Inst. Own | 97.67% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 50.62 | 200-d Avg | 54.09 | 1yr Est | 104.77 |
| Income Statement | |||
| Operating Expenses | 118.63M | ||
| Research and Development Expense | 100.06M | ||
| Selling, General and Administrative Expense | 18.57M | ||
| Operating Income | -118.63M | ||
| Income Tax Expense | 234.00K | ||
| Net Income | -106.16M | ||
| Net Income Common Stock | -106.16M | ||
| Net Income Common Stock (USD) | -106.16M | ||
| Consolidated Income | -106.16M | ||
| Earnings per Basic Share | -1.47 | ||
| Earnings per Basic Share (USD) | -1.47 | ||
| Earnings per Diluted Share | -1.47 | ||
| Earning Before Interest & Taxes (EBIT) | -105.92M | ||
| Earning Before Interest & Taxes (USD) | -105.92M | ||
| Weighted Average Shares | 217.96M | ||
| Weighted Average Shares Diluted | 217.96M | ||
| Balance Sheet | |||
| Cash and Equivalents | 272.64M | ||
| Cash and Equivalents (USD) | 272.64M | ||
| Investments | 1.07B | ||
| Investments Current | 1.07B | ||
| Current Assets | 1.37B | ||
| Property, Plant & Equipment Net | 12.39M | ||
| Total Assets | 1.43B | ||
| Debt Current | 2.60M | ||
| Total Debt | 6.23M | ||
| Current Liabilities | 66.11M | ||
| Debt Non-Current | 3.63M | ||
| Total Liabilities | 71.01M | ||
| Accumulated Retained Earnings (Deficit) | -652.43M | ||
| Accumulated Other Comprehensive Income | -3.44M | ||
| Shareholders Equity | 1.35B | ||
| Shareholders Equity (USD) | 1.35B | ||
| Assets Non-Current | 53.39M | ||
| Total Debt (USD) | 6.23M | ||
| Liabilities Non-Current | 4.90M | ||
| Trade and Non-Trade Payables | 11.13M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.30M | ||
| Net Cash Flow from Financing | 2.09M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -43.53M | ||
| Capital Expenditure | 42.00K | ||
| Issuance (Purchase) of Equity Shares | 2.09M | ||
| Net Cash Flow from Investing | 74.50M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 74.46M | ||
| Net Cash Flow from Operations | -120.11M | ||
| Share Based Compensation | 12.63M | ||